Advertisement

Radiological Imaging in Oesophageal and Gastric Cancers

  • Ayshea Hameeduddin
Chapter
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

Imaging modalities used to assess carcinoma of the oesophagus and stomach include barium studies, endoscopic ultrasound (EUS), multi-detector CT (MDCT), magnetic resonance imaging (MRI) and PET-CT (see separate chapter). Historically, patients who presented with dysphagia were frequently referred for a barium swallow study if an irregular stricture was identified they proceeded to endoscopy for diagnosis. Assessment of the stomach with barium required a double-contrast study with contrast and air to detect and localise a gastric tumour; however due to advances in endoscopy, EUS and MDCT, the use of barium studies has declined [1].

Keywords

Gastric Carcinoma Oesophageal Carcinoma Irregular Stricture Multimodality Imaging Approach Hepatoduodenal Lymph Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lee MH, Choi D, Park MJ, Lee MW. Gastric cancer: imaging and staging with MDCT based on the 7th AJCC guidelines. Abdom Imaging. 2012;37(4):531–40.CrossRefPubMedGoogle Scholar
  2. 2.
    Kim TJ, Kim HY, Lee KW, Kim MS. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2009;29(2):403–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol. 2007;25(15):2107–16.CrossRefPubMedGoogle Scholar
  4. 4.
    Murata Y, Suzuki S, Ohta M, Mitsunaga A, Hayashi K, Yoshida K, et al. Small ultrasonic probes for determination of the depth of superficial esophageal cancer. Gastrointest Endosc. 1996;44(1):23–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Lightdale CJ, Kulkarni KG. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol. 2005;23(20):4483–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Godoy MC, Bruzzi JF, Viswanathan C, Truong MT, Guimaraes MD, Hofstetter WL, et al. Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications. Abdom Imaging. 2013;38(5):974–93.CrossRefPubMedGoogle Scholar
  7. 7.
    Desai RK, Tagliabue JR, Wegryn SA, Einstein DM. CT evaluation of wall thickening in the alimentary tract. Radiographics. 1991;11(5):771–83. discussion 84.CrossRefPubMedGoogle Scholar
  8. 8.
    Casson AG, Darnton SJ, Subramanian S, Hiller L. What is the optimal distal resection margin for esophageal carcinoma? Ann Thorac Surg. 2000;69(1):205–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Catalano MF, Sivak Jr MV, Rice T, Gragg LA, Van Dam J. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40(4):442–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA, Eloubeidi MA. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg. 2005;129(6):1232–41.CrossRefPubMedGoogle Scholar
  11. 11.
    Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review. Radiology. 2005;236(3):841–51.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Radiology and Nuclear MedicineBarts Health NHS TrustLondonUK

Personalised recommendations